Hot or Not, Stock Market Edition: 11/19/2026

By Jessie Moore, Stock Researcher and Writer
November 19, 2026 5:53 AM UTC
Hot or Not, Stock Market Edition: 11/19/2026

Happy Thursday. Here’s what the Zen Ratings are pressing play on and powering down today:

  • 🔥 Hot: Consumer electronics and entertainment giant Sony (SONY) just raised guidance as gaming and film profits accelerate; biotech heavyweight Biogen (BIIB) is rallying as its Alzheimer’s franchise gains traction and earnings expectations improve.
  • 🥶 Not: Gaming platform Roblox (RBLX) is losing engagement as competition for players intensifies; lithium developer Lithium Americas (LAC) is down nearly 80% while the cost of its flagship project keeps climbing.

P.S. For more stocks making moves, check out our Zen Ratings Upgrades & Downgrades screener.


A note from our sponsors...

The ONLY AI opportunity you should be looking at

This is the ONLY AI wealth-building opportunity you should be watching right now.

No. It's not about Nvidia, Tesla, or Meta...

It's about one overlooked company profiting off AI "digital goldmines" that are poised to experience 100x growth very soon.

This new opportunity will change the market and make investors a lot of money.

That's why it has received a $500 billion commitment from President Trump himself...

Learn more about this little-known company here >>>


🔥 HOT: Entertainment and electronics giant Sony (SONY) has multiple engines working at once. Quarterly profit jumped 45%, management raised its full-year outlook, PlayStation remains a powerhouse, and a strong film slate is giving Sony Pictures another boost. Investors have noticed: shares have climbed more than 40% from their 52-week low as stronger gaming and entertainment results change the earnings story.

SONY has a Zen Rating of B, a Buy recommendation. Sentiment earns an A, while Artificial Intelligence gets a B, showing that analyst expectations and the forward outlook continue to improve. Bottom line: Sony isn’t relying on one blockbuster product. Gaming, movies, and a raised outlook are all contributing to a recovery that is already gaining traction.

🥶 NOT: Gaming platform Roblox (RBLX) has a problem that matters more than almost any financial metric: engagement is weakening. Daily users and other engagement measures slipped in the latest quarter, the stock plunged on the news, and GTA VI threatens to compete for even more gaming hours. Shares have now lost more than half their value from their 52-week high, suggesting investors are taking the slowdown seriously.

RBLX has a Zen Rating of C, a Hold recommendation. Value and Momentum both earn D grades, while nothing on the card scores above C. That means the stock remains difficult to justify on valuation while the market trend is moving against it. Bottom line: Roblox still has a massive platform, but falling engagement is exactly the kind of problem a platform business cannot afford to ignore.

🔥 HOT: Biotech giant Biogen (BIIB) is finally turning years of pipeline promises into a credible comeback. Earnings and revenue beat expectations, analysts raised forecasts, and longer-term Leqembi data is strengthening the case for its Alzheimer’s franchise. Other pipeline programs are delivering encouraging results too. Investors have responded: shares have rallied nearly 60% from their 52-week low.

BIIB has a Zen Rating of B, a Buy recommendation. Stocks in this tier have historically beaten the S&P by nearly 2 to 1, so they’re usually worth a closer look. And there’s more to like here when you look at the Component Grades that underlie the overall rating, Value, Momentum, and Safety all earn above-average B grades. This suggests that the rebound still has fundamental support behind it rather than being driven by pipeline excitement alone. Bottom line: Biogen’s Alzheimer’s business is gaining credibility, earnings expectations are surging, and the stock’s big recovery reflects a company finally returning to growth.

🥶 NOT: Lithium developer Lithium Americas (LAC) just made an already difficult investment case harder. The estimated cost of its flagship Thacker Pass project jumped 31%, yet the company still generates no revenue and faces billions in future cash needs. Meanwhile, weaker lithium conditions are putting additional pressure on the economics.

Shares have collapsed nearly 80% from their 52-week high, and the funding problem helps explain why.

LAC has a Zen Rating of F, a Strong Sell recommendation. The Component Grades tell the story: Momentum earns an F, while Value, Sentiment, Safety, Financials, and Artificial Intelligence all receive D grades. That points to weakness extending far beyond the share price. Bottom line: Thacker Pass may eventually become an important U.S. lithium asset, but rising costs and a multibillion-dollar funding need leave current shareholders carrying much of the risk.

What to Do Next?

Want to get in touch? Email us at news@wallstreetzen.com.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.